Methyl mercury pharmacokinetics in man: a five-compartment hybrid model
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study presents a human pharmacokinetic model for methyl mercury (MeHg) and inorganic mercury (Hg(II)). Simulations show most MeHg demethylation occurs in the gut lumen, impacting mercury biotransformation.
Area Of Science
- Environmental Health
- Toxicology
- Pharmacokinetics
Background
- Methylmercury (MeHg) is a neurotoxin with complex biotransformation pathways in humans.
- Inorganic mercury (Hg(II)) is a demethylation product of MeHg with distinct toxicokinetics.
- Understanding mercury's fate in the body is crucial for risk assessment.
Purpose Of The Study
- To develop and validate a five-compartment hybrid pharmacokinetic model for MeHg and Hg(II) in humans.
- To quantify the contribution of different body sites to MeHg demethylation.
- To simulate the impact of altered demethylation on mercury pharmacokinetics.
Main Methods
- A five-compartment hybrid model integrating MeHg and Hg(II) pharmacokinetics was developed.
- The model incorporates demethylation of MeHg in both the gut lumen and body tissues.
- Model parameters for Hg(II) pharmacokinetics were based on Farris et al.'s two-compartment model.
- The model was validated using experimental data from two human subjects dosed with MeHg.
Main Results
- Simulations indicate that approximately 85% of MeHg demethylation occurs in the gut lumen, with 15% occurring in body tissues.
- The model successfully simulates mercury pharmacokinetic behavior in humans.
- Simulations explore scenarios of reduced MeHg biotransformation in the gastrointestinal tract.
Conclusions
- The developed model provides a robust framework for studying human MeHg and Hg(II) pharmacokinetics.
- The gut lumen plays a dominant role in MeHg demethylation.
- This model can aid in assessing human health risks associated with methylmercury exposure.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...
Multicompartmental models are crucial tools in pharmacokinetics, providing a framework to understand how drugs move within the body. The two-compartment model is a crucial subtype, segmenting the body into central and peripheral compartments. The central compartment represents areas with high blood flow, such as plasma and highly perfused organs like the kidneys and liver, while the peripheral compartment signifies tissues with lower blood flow, like adipose tissue and muscle tissue.
The...
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...